EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The complement system in neurodegenerative diseases

Jacqui Nimmo, Robert A J Byrne, Nikoleta Daskoulidou, Lewis M Watkins, Sarah M Carpanini, Wioleta M Zelek, B Paul Morgan iD

Clinical Science · 20.03.2024 · 138 (6) · 387-412

DOI: 10.1042/cs20230513 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Science, online erschienen am 20.03.2024. Verfasst von Jacqui Nimmo und 6 weiteren Autor:innen. Beteiligte Einrichtung: UK Dementia Research Institute Cardiff, Cardiff University, Cardiff CF24 4HQ, U.K. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Alzheimer Disease, Multiple Sclerosis, Parkinson Disease. Die Arbeit wurde bisher 62-mal zitiert (Crossref) und nennt 263 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UK Dementia Research Institute (UK DRI).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Complement is an important component of innate immune defence against pathogens and crucial for efficient immune complex disposal. These core protective activities are dependent in large part on properly regulated complement-mediated inflammation. Dysregulated complement activation, often driven by persistence of activating triggers, is a cause of pathological inflammation in numerous diseases, including neurological diseases. Increasingly, this has become apparent not only in well-recognized neuroinflammatory diseases like multiple sclerosis but also in neurodegenerative and neuropsychiatric diseases where inflammation was previously either ignored or dismissed as a secondary event. There is now a large and rapidly growing body of evidence implicating complement in neurological diseases that cannot be comprehensively addressed in a brief review. Here, we will focus on neurodegenerative diseases, including not only the ‘classical’ neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease, but also two other neurological diseases where neurodegeneration is a neglected feature and complement is implicated, namely, schizophrenia, a neurodevelopmental disorder with many mechanistic features of neurodegeneration, and multiple sclerosis, a demyelinating disorder where neurodegeneration is a major cause of progressive decline. We will discuss the evidence implicating complement as a driver of pathology in these diverse diseases and address briefly the potential and pitfalls of anti-complement drug therapy for neurodegenerative diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurodegenerative DiseasesAlzheimer DiseaseMultiple SclerosisParkinson DiseaseHumansInflammation

Stichwörter der Autor:innen

complementdementiainflammation

Autor:innen und Institutionen

  • UK Dementia Research Institute Cardiff, Cardiff University, Cardiff CF24 4HQ, U.K.

ORCID-Profile: B Paul Morgan

Förderung

  • UK Dementia Research Institute (UK DRI)

Zitieren

APA

Nimmo, J., Byrne, R. A. J., Daskoulidou, N., Watkins, L. M., Carpanini, S. M., Zelek, W. M., & Morgan, B. P. (2024). The complement system in neurodegenerative diseases. Clinical Science, 138(6), 387-412. https://doi.org/10.1042/cs20230513

Vancouver

Nimmo J, Byrne RAJ, Daskoulidou N, Watkins LM, Carpanini SM, Zelek WM, et al. The complement system in neurodegenerative diseases. Clinical Science. 2024;138(6):387-412. doi:10.1042/cs20230513

BibTeX
@article{Nimmo2024,
  author = {Nimmo, Jacqui and Byrne, Robert A J and Daskoulidou, Nikoleta and Watkins, Lewis M and Carpanini, Sarah M and Zelek, Wioleta M and Morgan, B Paul},
  title = {The complement system in neurodegenerative diseases},
  journal = {Clinical Science},
  year = {2024},
  volume = {138},
  number = {6},
  pages = {387--412},
  doi = {10.1042/cs20230513}
}
Kostenlos starten →